openPR Logo
Press release

HIV Therapeutics Market: Key Players, Growth, Analysis by 2020

06-27-2017 03:11 PM CET | Health & Medicine

Press release from: Persistence Market Research

HIV Therapeutics Market: Key Players, Growth, Analysis by 2020

The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease. HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy.

Get access to full summary @: http://www.persistencemarketresearch.com/market-research/hiv-therapeutics-market.asp

Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches. HIV infection has no cure but there are treatments which help to stabilize or reduce this infection so that it does not lead to AIDS. HIV therapeutics market is growing at a significant rate due to increase in the HIV infected cases and growing awareness about the same. HIV infection can be treated by various therapeutics such as nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor.

North America, followed by Europe, has the largest market for HIV therapeutics due to affordability and accessibility of expensive treatment for HIV infection and innovations in drug therapies in this region. Asia is expected to show high growth rate in the HIV therapeutics market in next few years due to increasing number of HIV infected population and increasing research activities for developing HIV drugs and vaccines in the region.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3339

Increasing number of HIV infection cases, technological advancement in HIV diagnosis and therapeutics, rise in research activities for developing HIV vaccines and lack of awareness about the modes of transmission of the virus are driving the global market for HIV therapeutics. In addition, increasing awareness about the availability of HIV therapeutics in the market and cost effective drug therapies for HIV are driving the global HIV therapeutics market. However, various factors such as failure of treatment in some cases, lack of skilled professionals and introduction of generic drugs in the market are restraining the HIV therapeutics market.

Growing demographics and economies in the developing countries such as India and China are expected to offer good opportunities for HIV therapeutics market. In addition, rise in awareness about the availability of treatment of HIV infection are expected to offer new opportunity to global HIV therapeutics market. One of the latest trends that have been observed in the HIV therapeutics market includes companies involved in new product launches.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3339

Some of the major companies dealing in HIV therapeutics are GlaxoSmithKline, Bristol-Myers Squibb, Pfizer and Boehringer Ingelheim. Other companies having significant presence in HIV therapeutics market are Merck, Hoffmann-La Roche and Gilead Sciences.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HIV Therapeutics Market: Key Players, Growth, Analysis by 2020 here

News-ID: 598473 • Views:

More Releases from Persistence Market Research

Medical Laser Technology Market Set to Witness Robust Growth to Reach US$13.8 Bn by 2032
Medical Laser Technology Market Set to Witness Robust Growth to Reach US$13.8 Bn …
The medical laser technology market plays a pivotal role in advancing healthcare by enabling minimally invasive procedures, precise surgical interventions, and high-resolution diagnostic imaging. Medical lasers are widely used in dermatology, ophthalmology, oncology, dentistry, and cosmetic surgery due to their accuracy, controlled tissue interaction, and faster patient recovery. According to the latest study by Persistence Market Research, the market is projected to grow from US$6.8 Bn in 2025 to US$13.8
Atomic Magnetometers Market Set to Soar to US$3.2 Bn by 2032 with 15% CAGR
Atomic Magnetometers Market Set to Soar to US$3.2 Bn by 2032 with 15% CAGR
The atomic magnetometers market is playing a pivotal role in advancing high-precision magnetic field detection across diverse applications, including defense, biomedical research, space exploration, and industrial sensing. These devices leverage quantum properties of atoms to measure extremely weak magnetic fields with exceptional sensitivity, offering unmatched accuracy, stability, and reliability. According to the latest study by Persistence Market Research, the global atomic magnetometers market is likely to be valued at US$1.2
Disposable Blood Bags Market Set for a Major Boom, Expected to Reach US$765.6 Mn by 2032
Disposable Blood Bags Market Set for a Major Boom, Expected to Reach US$765.6 Mn …
The disposable blood bags market plays a critical role in ensuring safe, efficient, and contamination-free blood collection, storage, and transfusion processes. These products are extensively used in hospitals, blood banks, diagnostic laboratories, and other healthcare facilities. Disposable blood bags offer superior safety, sterility, and convenience, minimizing the risk of infection and improving patient care outcomes. According to the latest study by Persistence Market Research, the global market is anticipated to
Balloon Infusers Market Booming and Set to Reach US$2.3 Bn by 2032 PMR Report
Balloon Infusers Market Booming and Set to Reach US$2.3 Bn by 2032 PMR Report
The balloon infusers market is witnessing remarkable growth, driven by the rising adoption of minimally invasive procedures, targeted drug delivery systems, and advanced cardiovascular interventions. Balloon infusers play a critical role in precision medicine, enabling controlled administration of therapeutic agents, localized treatment, and reduced systemic side effects, thereby enhancing patient outcomes and safety. Request a Sample: https://www.persistencemarketresearch.com/samples/32517 According to the latest study by Persistence Market Research, the global balloon infusers market size

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways